US Study Finds 1 in 10 Get Long COVID After Omicron, Starts Identifying Key Symptoms
A U.S. study suggests 1 in 10 people are getting long COVID after an omicron infection.
The Latest
-
CDC's Rochelle Walensky Resigns, Citing Pandemic Transition
The head of the Centers for Disease Control and Prevention is resigning. Dr. Rochelle Walensky says the waning of the COVID-19 pandemic is a good time to make a transition. She sent a resignation letter to President Joe Biden and announced the decision at a CDC staff meeting Friday.
-
WHO Downgrades COVID Pandemic, Says It's No Longer Emergency
The World Health Organization says that COVID-19 no longer qualifies as a global emergency. The announcement on Friday marks a symbolic end to the devastating coronavirus pandemic that triggered once-unthinkable lockdowns, upended economies worldwide and killed at least 7 million people worldwide.
-
Biden Will End Covid Vaccine Mandates for Federal Workers and International Travelers on May 11
The Biden administration will end Covid vaccine mandates for federal employees, contractors and air travelers on May 11.
-
Lose Your Sense of Smell From COVID? New Brain Study Tackles Key Questions
The research shows it may be possible to retrain the brain to recover its sense of smell.
-
DOJ Charges 18 People — Including Doctors — in Massive Covid Health-Care Fraud Takedowns
The alleged health-care fraud schemes involved false billing and theft from federal programs, fake Covid vaccine cards, and Covid test kits.
-
CDC Signs Off on 2nd Dose of Omicron Covid Booster for Older Adults
The Centers for Disease Control and Prevention on Wednesday backed a second dose of the updated Covid booster for older adults and people with weakened immune systems.
-
FDA Clears Extra COVID Booster for Some High-Risk Americans
U.S. regulators on Tuesday cleared another booster dose of the Pfizer or Moderna COVID-19 vaccines for older Americans and people with weak immune systems.
-
Pfizer's Covid Drug Paxlovid May Reduce the Risk of Developing Long Covid, Study Says
People who took Pfizer’s antiviral treatment Paxlovid shortly after infection saw a 26% lower risk of long Covid compared with those who didn’t, the study said.
-
Senators Press Moderna CEO on COVID-19 Vaccine Price Hike
Moderna’s CEO is defending a plan to more than quadruple the company’s COVID-19 vaccine price.
-
If You Had Covid Before You Were Vaccinated, You Might Have Less Immunity Than You Think, Study Says
The study, led by Stanford University researchers, challenges prior studies that suggest a Covid infection enhances a vaccinated individual’s immune response.
-
Biden Signs Legislation to Declassify Certain Intelligence on Covid Pandemic Origins
Biden signed legislation requiring the declassification of information on any possible links between a lab in China and the origins of the Covid-19 pandemic.
-
New COVID Origins Data Suggest Pandemic Linked to Raccoon Dogs at Wuhan Market
Genetic material collected at a Chinese market near where the first human cases of COVID-19 were identified show raccoon dog DNA comingled with the virus, suggesting the pandemic may have originated from animals, not a lab, international experts say.
-
Study Calls COVID's Mental Health Impact ‘Minimal.' The Responses Perfectly Capture 2020
‘It’s a way to speak back to the idea that all harm is measurable,’ according to a psychologist.
-
FDA Staff Report Says Data Shows Pfizer's Covid Treatment Paxlovid Is Effective in High-Risk Adults
FDA staff said Pfizer’s clinical trial results on its Covid antiviral pill Paxlovid support its use in adults at high risk of progressing to severe disease.
